These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17621271)

  • 1. POU2AF1, an amplification target at 11q23, promotes growth of multiple myeloma cells by directly regulating expression of a B-cell maturation factor, TNFRSF17.
    Zhao C; Inoue J; Imoto I; Otsuki T; Iida S; Ueda R; Inazawa J
    Oncogene; 2008 Jan; 27(1):63-75. PubMed ID: 17621271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome 11q23.1 is an unstable region in B-cell tumor cell lines.
    Poretti G; Kwee I; Bernasconi B; Rancoita PM; Rinaldi A; Capella C; Zucca E; Neri A; Tibiletti MG; Bertoni F
    Leuk Res; 2011 Jun; 35(6):808-13. PubMed ID: 21420167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma.
    Largo C; Alvarez S; Saez B; Blesa D; Martin-Subero JI; González-García I; Brieva JA; Dopazo J; Siebert R; Calasanz MJ; Cigudosa JC
    Haematologica; 2006 Feb; 91(2):184-91. PubMed ID: 16461302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant downregulation of proliferation/survival pathways dependent on FGF-R3, JAK2 and BCMA in human multiple myeloma cells by multi-kinase targeting.
    Cassinelli G; Ronchetti D; Laccabue D; Mattioli M; Cuccuru G; Favini E; Nicolini V; Greco A; Neri A; Zunino F; Lanzi C
    Biochem Pharmacol; 2009 Nov; 78(9):1139-47. PubMed ID: 19555670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma.
    Suzuki A; Iida S; Kato-Uranishi M; Tajima E; Zhan F; Hanamura I; Huang Y; Ogura T; Takahashi S; Ueda R; Barlogie B; Shaughnessy J; Esumi H
    Oncogene; 2005 Oct; 24(46):6936-44. PubMed ID: 16044163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-catenin small interfering RNA successfully suppressed progression of multiple myeloma in a mouse model.
    Ashihara E; Kawata E; Nakagawa Y; Shimazaski C; Kuroda J; Taniguchi K; Uchiyama H; Tanaka R; Yokota A; Takeuchi M; Kamitsuji Y; Inaba T; Taniwaki M; Kimura S; Maekawa T
    Clin Cancer Res; 2009 Apr; 15(8):2731-8. PubMed ID: 19351774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a potential role for POU2AF1 and BTG4 in the deletion of 11q23 in chronic lymphocytic leukemia.
    Auer RL; Starczynski J; McElwaine S; Bertoni F; Newland AC; Fegan CD; Cotter FE
    Genes Chromosomes Cancer; 2005 May; 43(1):1-10. PubMed ID: 15672409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and biological characterization of three novel interleukin-6-dependent human myeloma cell lines.
    Verdelli D; Mattioli M; Fabris S; Nobili L; Intini D; Guerneri S; Todoerti K; Zanella A; Deliliers GL; Lombardi L; Neri A
    Haematologica; 2005 Nov; 90(11):1541-8. PubMed ID: 16266902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2F3 is the main target gene of the 6p22 amplicon with high specificity for human bladder cancer.
    Oeggerli M; Schraml P; Ruiz C; Bloch M; Novotny H; Mirlacher M; Sauter G; Simon R
    Oncogene; 2006 Oct; 25(49):6538-43. PubMed ID: 16953223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma.
    Tan KD; Zhu Y; Tan HK; Rajasegaran V; Aggarwal A; Wu J; Wu HY; Hwang J; Lim DT; Soo KC; Tan P
    Genes Chromosomes Cancer; 2008 Apr; 47(4):353-62. PubMed ID: 18196592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and transcriptional characterization of the novel 17p11.2-p12 amplicon in multiple myeloma.
    Fabris S; Todoerti K; Mosca L; Agnelli L; Intini D; Lionetti M; Guerneri S; Lambertenghi-Deliliers G; Bertoni F; Neri A
    Genes Chromosomes Cancer; 2007 Dec; 46(12):1109-18. PubMed ID: 17823926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of primary MAFB target genes in multiple myeloma.
    van Stralen E; van de Wetering M; Agnelli L; Neri A; Clevers HC; Bast BJ
    Exp Hematol; 2009 Jan; 37(1):78-86. PubMed ID: 19013005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule inhibition of proteasome and silencing by vascular endothelial cell growth factor-specific siRNA induce additive antitumor activity in multiple myeloma.
    Koldehoff M; Beelen DW; Elmaagacli AH
    J Leukoc Biol; 2008 Aug; 84(2):561-76. PubMed ID: 18458152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the 7q21-q22 amplicon identifies ARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion in pancreatic cancer.
    Laurila E; Savinainen K; Kuuselo R; Karhu R; Kallioniemi A
    Genes Chromosomes Cancer; 2009 Apr; 48(4):330-9. PubMed ID: 19145645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of the c-myc and the pvt-like region in human multiple myeloma.
    Bakkus MH; Brakel-van Peer KM; Michiels JJ; van 't Veer MB; Benner R
    Oncogene; 1990 Sep; 5(9):1359-64. PubMed ID: 2216459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation.
    Fionda C; Soriani A; Malgarini G; Iannitto ML; Santoni A; Cippitelli M
    J Immunol; 2009 Oct; 183(7):4385-94. PubMed ID: 19748980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of SERTAD3, a putative oncogene located within the 19q13 amplicon, induces E2F activity and promotes tumor growth.
    Darwish H; Cho JM; Loignon M; Alaoui-Jamali MA
    Oncogene; 2007 Jun; 26(29):4319-28. PubMed ID: 17260023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer.
    Medina PP; Castillo SD; Blanco S; Sanz-Garcia M; Largo C; Alvarez S; Yokota J; Gonzalez-Neira A; Benitez J; Clevers HC; Cigudosa JC; Lazo PA; Sanchez-Cespedes M
    Hum Mol Genet; 2009 Apr; 18(7):1343-52. PubMed ID: 19153074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of ZNF217 gene influences the biological behavior of a human ovarian cancer cell line.
    Sun G; Zhou J; Yin A; Ding Y; Zhong M
    Int J Oncol; 2008 May; 32(5):1065-71. PubMed ID: 18425333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of PDZK1 within the 1q12-q22 amplicon is likely to be associated with drug-resistance phenotype in multiple myeloma.
    Inoue J; Otsuki T; Hirasawa A; Imoto I; Matsuo Y; Shimizu S; Taniwaki M; Inazawa J
    Am J Pathol; 2004 Jul; 165(1):71-81. PubMed ID: 15215163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.